State Of Alaska, Department Of Revenue Catalyst Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $8.82 Billion
- Q1 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 62,123 shares of CPRX stock, worth $1.58 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
62,123
Previous 63,719
2.5%
Holding current value
$1.58 Million
Previous $1.33 Million
13.32%
% of portfolio
0.02%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CPRX
# of Institutions
389Shares Held
99.3MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$474 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$215 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$140 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$86.8 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$79.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.61B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...